Kalkine has a fully transformed New Avatar.

KALIN®

Kalkine Daily 20/03/2015 + MYER

Mar 20, 2015

In today’s daily we have covered stock research on MYER (Expensive).








 

The S&P 500 was down by 8.90  points or 0.43% on Thursday and closed at 2090.47 points. U.S. stocks fell on Thursday in a reversal of the previous day's action, as a stronger dollar weighed on oil and other commodity prices sending energy and materials sectors lower. The energy sector ended the day 1.7 per cent lower as oil prices stayed under pressure, forcing the S&P 500 to give up some of the gains it notched on Wednesday after the Federal Reserve struck a cautious note on interest rates. Oil rig owner Transocean was the worst performing stock on the blue-chip, after the company said it would scrap four rigs and take a first-quarter charge of $300m to $325m. SouthWestern EnergyDenbury Resources and Noble Corp were among the worst performing shares within the S&P 500 energy sector.

Home builder Lennar Corp. reported stronger-than-expected results in the first quarter as a continuing recovery in the housing market led to a rise in deliveries and prices. Shares fell 1.3%. Shares of Target Corp. fell 0.5% after announcing plans to boost the pay of all its workers to at least $9 an hour starting next month, following similar moves by rivals Wal-Mart Stores Inc. and TJX Cos. European markets were mixed. Germany’s DAX slipped 0.2% while France’s CAC 40 gained 0.1%.



Target Daily Chart (Source - Thomson Reuters)
 

S&P ASX 200 was up by 108.5  points on Thursday and closed at 5950.8 points.Commonwealth Bank of Australia led the gains as it added 2.4 per cent to a new all-time high of $95.61. Westpac Banking Corp likewise pushed to a new record, up 2.7 per cent at $39.71.ANZ Banking Group also recorded its highest ever close, gaining 2 per cent to $36.63. National Australia Bank jumped 2.2 per cent to a seven-year high of $39.24.

Telstra Corp, another high-yield favourite, lifted 1.8 per cent to $6.41. Plasma product and vaccine exporter CSL added 1.7 per cent to a record close of $95.22, making it the highest-priced stock on the ASX. Department store operator Myer Holdings was the worst-performing stock in the ASX 200, dumping 10.1 per cent to $1.38 after slashing its full-year profit guidance as the group's half-year results missed expectations following a weak February.  Sigma Pharmaceuticals was the top performer, up 9.3 per cent to 94¢. The Australian dollar is trading at US76.16¢. The currency surged about 2¢ to US78.48¢ in early Sydney trade on Thursday, as the US dollar tumbled.


Sigma Pharmaceuticals Daily Chart (Source – Thomson Reuters)


Top 25 Dividend Stocks - Click Here

 
Top Performers on the ASX 200 were :-

 


 

Get up to 2 Years of free subscription by inviting your friends to KALKINE!

For every friend of yours who joins KALKINE, we'll give you 3 months of free subscription (up to a limit of 24 months free subscription). If you recommend 3 friends and they join within a month of you referring them, you get 1 year free subscription to KALKINE reports added to your account (up to a limit of 24 months free subscription). Simply reply to this email with their name, e-mail and phone number.
 


MYER Video




 

Stock Of the Day  - MYER  (Expensive)

There is a little disappointment with regards to the Myer Holdings Limited (MYR) results reported for 26 weeks to 24 January 2015. Specifically, the net profit after tax (NPAT) was down 23.1% to $62.2 million. Earnings before interest, tax, depreciation, amortisation (EBITDA) dipped 15.6% to $145.3 million. Further, earnings before interest and tax (EBIT) was down 20.8% to $100.2 million.


Cash Cost of Doing Business (Source – Company Reports)

Another sinking point has been the 6.2% rise in cash cost of doing business (CCODB) to $569.6 million. The underlying costs were reported to be up 2.4% along with $20 million investment in the business. The $20 million were primarily spent on revenue generating initiatives such as Myer’s brand re-launch, refurbishing of stores and opening of new stores, IT infrastructure, and so forth. The operating gross profit went up 0.9% to $714.9 million while the operating gross profit margin dipped 24 basis points to 40.54%. This was primarily owing to the increase in competition and impact of weaker Australian dollar. What we note is that the trading conditions were challenging in second quarter and there was improvement in late December. Operating cash-flow dropped 25.3% to $194 million as opposed to $259 million of 1H FY2014, owing to the above-mentioned investments and condensed earnings.

The Company declared an interim dividend (fully franked) of 7 cents per share which is to be paid on 7 May 2015. This seems to be resulting from the Company’s confidence on its balance sheet position and robust cash generation capability. However, MYR reported that its net debt rose by 13.7% to $261 million.

With regards to the sales trend, the Company announced a 1.5% increase in 1H FY2015 total sales to $1,763 million which is up 0.9% on a comparable store sales basis with cosmetics category being the outperformer. There has been a 2.5% increase in Q2 total sales to $1,072 million which is up 1.0% on a comparable store sales basis. The total sales surged 3.9% in January 2015. In fact, continued strong growth in online sales was another positive. However, the Company conveyed that the sales although have been better than prior corresponding period but below expectations which is of course not a good indication. The challenging trading environment, drag in womenswear, disruption from Macquarie and Miranda refurbishments and Pacific Fair centre refurbishment have been highlighted as the tailbacks.


Sales Growth and Mix (Source – Company Reports)

As per the Company’s FY2015 downgraded outlook, it anticipates a continuation of the operating gross profit margin pressure into the second half. Specifically, a decrease in second half operating gross profit margin of 15-30 basis points compared to 2H FY2014 has been stated. Further, total costs are expected to grow by about $15 million in the second half in comparison to 2H FY2014. MYR conveyed that it expects the one-off costs in 2H with regards to the strategic review to be about $7 million. The FY2015 NPAT is also projected to be between $75-80 million (excluding one-off costs) with 2H FY2015 NPAT to be between $13-18 million. In our view, the commentary on strategic review looked quite subjective without specific directionality.

In view of the fact that the guidance is falling short of estimates, it is unclear why the Company did not cut the guidance while announcing for few management changes sometime back. The Company stated its unawareness about sales drop at the time of announcing the changes. This brings MYR’s compliance with regards to the continuous disclosure law in question. The trading of two new stores, completion of four major refurbishments, opening of additional space in Emporium adjoining the Melbourne flagship store ahead of Christmas trading period were thought to bring some gains earlier.


Operating Gross Profit Margin (Source – Company Reports)

Success also prevailed with the launch of the Giftorium concept across all stores. Brand roll-out including White Suede, By Johnny and Alex Perry in Womenswear; M.J. Bale, Herringbone and Aquila in Menswear; and Calvin Klein Performance in Women’s Active, during the first half proved beneficial to some extent. New Australian and international brands since the start of the second half such as Maison Scotch, Skin and Threads, and Asilio in Womenswear; Jo Malone in Cosmetics; Scotch & Soda, and Pierre Balmain in Menswear; etc. also contributed towards another highlight. The Company however conveyed not proceeding with the proposed store at Greenhills in New South Wales. Even with these piecemeal success points, the overall result has been quite disappointing with the recent management changes coming in an ill-timed manner.



Given the foregoing, we still believe that the stock is EXPENSIVE at the current price of $1.375.
 
 


Level 13  167 Macquarie Street
Sydney NSW 2000 Australia
E-Mail - [email protected]
Phone - 02 8667 3147


        
Note - You can also view this daily in the special reports section.

 


Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people.
Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376).
The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation.
Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product.
The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide.